KRAS and familial pancreatic carcinoma: In pancreatic cancer, the oncogenic KRAS mutation is the main factor, provides irreversible protein KRAS induction, and functions as a signaling molecule to trigger different transcription factors and intracellular signaling pathways related to cell proliferation, differentiation, migration, and survival [96].